Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models-Reference-Cited by-同舟云学术

Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models

Published:2017-11-05 Issue:6 Volume:5 Page:e00368
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Zhang Yuanyuan¹,LaCerte Carl¹,Kansra Sanjay¹,Jackson Jonathan P.²,Brouwer Kenneth R.²,Edwards Jeffrey E.¹^ORCID

Affiliation:

1. Intercept Pharmaceuticals Inc.; San Diego CA USA

2. Qualyst Transporter Solutions, LLC; Durham NC USA

Funder

Intercept Pharmaceuticals, Inc.

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prp2.368/fullpdf

Reference40 articles.

1. Nuclear receptors in bile acid metabolism;Li;Drug Metab Rev,2013

2. Bile acid signaling in metabolic disease and drug therapy;Li;Pharmacol Rev,2014

3. Cholesterol 7 alpha-hydroxylase;Myant;J Lipid Res,1977

4. Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice;Zhang;J Lipid Res,2010

5. Separation of 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activities from clostridium absonum ATCC# 27555 and cellular response of this organism to bile acid inducers;Macdonald;J Lipid Res,1983

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suppressing FXR promotes antiviral effects of bile acids via enhancing the interferon transcription;Acta Pharmaceutica Sinica B;2024-08

2. Bioactivities, Mechanisms, Production, and Potential Application of Bile Acids in Preventing and Treating Infectious Diseases;Engineering;2024-07

3. Relationship between human serum metabolites and angina pectoris: a Mendelian randomization study;Postgraduate Medical Journal;2024-06-04

4. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets;Signal Transduction and Targeted Therapy;2024-04-26

5. Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis;Clinics and Research in Hepatology and Gastroenterology;2023-12